not tagged
sanofi
['sclc', 'nsclc', 'regeneron']
we re presenting information at #asco22 on the design of our clinical trial of investigational agents in patients with met-overexpressing #nsclc, a patient population in-need of therapeutic options. read more about the trial in progress here: 
Official channel for Regeneron. We turn science into medicine for people with serious diseases. View our terms of engagement here https://t.co/of3QRL6CsA